ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Holleb To Retire In June As ACS Vice President; Consensus Conference On Neurofibromatosis Set

January 23, 1987

Washington Braces For Oncologists; It’s The Spring Meetings

May 4, 1990

NMP22 Assay More Effective Than Conventional Lab Test

January 27, 2006

AGS-003 Increased Survival In Combination with Sunitinib

February 24, 2012

In Brief: LSU Will Be Headquarters For National Pancreatic Project; Budget For First Year Will Be $1 Million

December 6, 1974

Abstracts Of Papers Presented By Breast Cancer Task Force

September 17, 1976